Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2026-01-01 @ 2:23 PM
Study NCT ID:
NCT00908869
Status:
COMPLETED
Last Update Posted:
2012-01-30
First Post:
2009-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced Neoplasm
Sponsor:
Institut Paoli-Calmettes
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
METRO1/IPC2005-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None